ABOUT THE CONFERENCE
PharmaXcelerate 2026 is the leading regional platform dedicated to advancing excellence in pharmaceutical and biotech manufacturing, quality, and facility design. Taking place from 31 March – 2 April 2026 in Dubai, UAE, the summit will unite senior executives, manufacturing and quality leaders, regulators, and solution providers driving the future of compliant and efficient pharma production across the Middle East and beyond.
The event is structured around three core pillars: Engineering & Facility Design, highlighting digital transformation, cleanroom innovation, and sustainable operations; Manufacturing Excellence, focused on process optimization, technology transfer, and operational agility; and Quality & Compliance, addressing GMP readiness, validation, and sterile manufacturing best practices.
PharmaXcelerate will feature senior representatives from global leaders such as Pfizer, AstraZeneca, Sanofi, GSK, Roche, Johnson & Johnson, Merck, Novartis, and Bayer, alongside regional pioneers including Julphar, Hikma, SPIMACO, Riyadh Pharma, Jamjoom Pharma, Tabuk Pharmaceuticals, and Gulf Pharmaceutical Industries.
A distinctive element of the summit is the active participation of local pharmaceutical authorities and regulatory agencies, offering insight into national priorities, evolving standards, and regional market dynamics.
PharmaXcelerate 2026 is where the region’s pharma community connects to shape the future of resilient, high-quality, and sustainable manufacturing.
Select Currency:
*Before making your payment, please take a moment to choose your preferred currency. Your convenience matters to us, and selecting the right currency ensures a smooth transaction. Thank you for your attention to this detail!
Why this conference? Why now? Why Dubai?
PharmaXcelerate 2026 comes at a pivotal moment as the Middle East rapidly emerges as a global hub for pharmaceutical and biotech manufacturing. Driven by large-scale investments, localization initiatives, and Vision 2030 strategies, the region is transitioning from import dependency to advanced production and innovation. Hosting the conference in Dubai brings together global expertise and regional leadership to accelerate this transformation — fostering partnerships, technology transfer, and compliance excellence. Now is the time to align international best practices with regional ambitions, ensuring the Middle East becomes a center of resilient, high-quality, and sustainable pharmaceutical manufacturing.
SPEAKERS
Ulla Thomsen
Senior HVAC Specialist
Novonordisk, Denmark
Lara Masad
Manager, Quality Analytics & Compliance
Hikma Pharmaceuticals, Jordan
Aziz El Balboul
Associate Director Head of Middle East Life Science Process Solution
Merck KGaA, Germany
Vincent Stockman
Head of CQV - CSV Biologics Visp
Lonza, Switzerland
Caroline Emile Boules
Head of Quality - Italy
Johnson and Johnson. Italy
Varadharaj Vijayakumar
Senior Subject Matter Expert-Aseptic Fill Finish/Freeze Drying
Terumo Pharmaceutical Services GmbH, Germany
Haidy Kamel Saad
Director, Head of Regulatory Affairs
Novartis, United Arab Emirates
Mahmoud F. Moussa
Executive Quality Leader | Pharma & Biotech
Independent Consultant, Dubai, UAE
Yara Almouti
CEO
AGON, Jordan
Nicola Rutigliani
Aseptic Production Associate Director
Merck Group, Italy
Manel Fernandez
HVAC CQV Lead
Lonza, Switzerland
Lars Ravn Flodgaard
Director QC Environmental monitoring, Microbiology & Cleanrooms
ALK, Denmark
Andrea Campione
Aseptic Production Director
Merck Group, Italy
Rossella Bloise
Validation Manager
Merck Group, Italy
GOLD SPONSORS
PREMIUM EXHIBITOR
INDUSTRY PARTNER
MEDIA PARTNERS
